Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trial

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trial

Bibliographic Details
Main Authors: Yokoh, Hidetaka, Kobayashi, Kazuki, Sato, Yasunori, Takemoto, Minoru, Uchida, Daigaku, Kanatsuka, Azuma, Kuribayashi, Nobuichi, Terano, Takashi, Hashimoto, Naotake, Sakurai, Kenichi, Hanaoka, Hideki, Ishikawa, Ko, Onishi, Shunichiro, Yokote, Koutaro
Format: Online
Language:English
Published: BlackWell Publishing Ltd 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364853/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364853/

Similar Items